LEGACY GOOD SAMARITAN HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.5M
- Transactions
- 177
- Companies
- 24
- Average per transaction
- $14,319
Who reported the payments
| Merck | $1,144,902 |
| Tesaro, Inc. | $485,683 |
| A-dec, Inc. | $213,830 |
| Angiodynamics, Inc. | $135,500 |
| Astrazeneca UK Limited | $122,837 |
| Clovis Oncology, Inc. | $96,512 |
| Stryker | $71,062 |
| AstraZeneca | $57,919 |
| Pfizer | $53,500 |
| Daiichi Sankyo Inc. | $27,650 |
| Genmab U.S., Inc. | $27,650 |
| GSK | $25,610 |
| Abbott | $20,811 |
| Smith+Nephew | $14,193 |
| Linde Gas & Equipment Inc. | $13,505 |
| Pharmaand GmbH | $7,163 |
| Regeneron | $5,900 |
| Olympus America Inc. | $3,950 |
| Elekta, Inc. | $2,500 |
| Cochlear Americas | $1,125 |
| Acumed LLC | $1,035 |
| Zimmer Biomet | $772 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | $725 |
| Teleflex LLC | $51 |